NASDAQConsumer DiscretionaryApparel - Footwear & AccessoriesSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for WEYS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Dividend yield near 3% | It earns about $0.92 per share and pays a 3% dividend yield. | Intact | dividend yield falls below 2.5% or dividend cut announced | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 7–Nov 5 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
WEYS is a small-cap footwear business with a growth-led long-term thesis, rather than a turnaround story. The thesis is currently intact, and earnings quality is rated robust, though the next results remain a near-term watch point.
The valuation evidence describes WEYS as cheap versus peers, with a small expectations gap and a justified priced-in tag. The valuation measure has recently fallen, but the snapshot does not explain what expectations changed or give enough detail to call the shares cheap or expensive in absolute terms.
Recent performance is strong: second-quarter revenue grew 7% year over year, and Florsheim sales rose 12%. Tariff refunds lifted the reported gross margin, while management says it is still working to limit ongoing tariff effects, so that margin benefit may not represent the underlying run rate. Cash increased in the latest quarter, but a run of earnings misses makes the next report a near-term risk.
The next call is a key test: a guidance cut would be a meaningful negative, while continued organic growth would support the long-term thesis. Sector signals also matter, since continued strength from NKE, DECK, and CROX could sustain a helpful backdrop, while weaker results or guidance could remove that support. The September agreement and related financial obligation add a capital-allocation and execution factor, but the snapshot gives little detail about its terms.
Over the next 1 to 3 years, the case rests on continued brand-led growth, effective tariff management, and steady execution despite the recent earnings-miss run. The long-term thesis remains intact, but near-term confidence is limited by the next report and sparse details on the new obligation. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| It earns about $0.92 per share and pays a 3% dividend yield. |
| Intact |
| EPS falls below $0.81 in FY25 |
Diluted EPS: $1.39 per share FY2026-Q2; GAAP. Published target: >=0.81 USD per share. Annual target cannot be compared with a quarterly or TTM observation. Aug 7, 20261.39 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain profit margins near 15% | Weyco Group sells footwear with steady profit margins near 15%. | Improving | profit margin falls below 12% | Operating margin: 27.36% FY2026-Q2; GAAP. Published target: around 15%. Target period is not explicitly aligned with this observation. Aug 7, 202627.356307 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Limit revenue decline to no worse than -7% next year | A primary condition in Weyco Group, Inc.'s published investment case. The stated target is >= -7.3% YoY. | Intact | revenue decline worse than -7.3% YoY next year | Revenue growth: 6.86% FY2026-Q2; GAAP. Published target: >= -7.3% YoY. Reported actuals cannot certify a consensus target without an explicit period and accounting-basis binding. Aug 7, 20266.861785 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.